DNAJC9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.518200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.554600E-01
Normal-vs-Stage2
8.596000E-01
Normal-vs-Stage3
7.200600E-01
Normal-vs-Stage4
4.008400E-01
Stage1-vs-Stage2
9.638200E-01
Stage1-vs-Stage3
5.094400E-01
Stage1-vs-Stage4
2.186000E-01
Stage2-vs-Stage3
3.924000E-01
Stage2-vs-Stage4
2.075600E-01
Stage3-vs-Stage4
7.761200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.364600E-01
Normal-vs-AfricanAmerican
9.732200E-01
Normal-vs-Asian
9.153000E-01
Caucasian-vs-AfricanAmerican
7.300600E-01
Caucasian-vs-Asian
8.212000E-01
AfricanAmerican-vs-Asian
8.481000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.587800E-01
Normal-vs-Female
8.578200E-01
Male-vs-Female
9.573400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.590600E-01
Normal-vs-Age(41-60Yrs)
6.066000E-01
Normal-vs-Age(61-80Yrs)
9.810600E-01
Normal-vs-Age(81-100Yrs)
5.948400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.578000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.666800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.057000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.754400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.631000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.773400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.906400E-01
Normal-vs-Daily Drinker
6.575800E-01
Normal-vs-Weekly Drinker
7.052000E-01
Normal-vs-Occasional Drinker
6.203400E-01
Normal-vs-Social Drinker
6.947800E-01
Non Drinker-vs-Daily Drinker
3.199800E-01
Non Drinker-vs-Weekly Drinker
4.430600E-01
Non Drinker-vs-Occasional Drinker
3.172200E-01
Non Drinker-vs-Social Drinker
4.146000E-01
Daily Drinker-vs-Weekly Drinker
9.252000E-01
Daily Drinker-vs-Occasional Drinker
9.811400E-01
Daily Drinker-vs-Social Drinker
9.512800E-01
Weekly Drinker-vs-Occasional Drinker
9.069800E-01
Weekly Drinker-vs-Social Drinker
9.755800E-01
Occasional Drinker-vs-Social Drinker
9.335800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.571200E-01
Normal-vs-Grade 2
9.447600E-01
Normal-vs-Grade 3
9.860400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.085500E-02
Grade 1-vs-Grade 3
1.424330E-02
Grade 1-vs-Grade 4
8.571200E-01
Grade 2-vs-Grade 3
2.848000E-01
Grade 2-vs-Grade 4
9.447600E-01
Grade 3-vs-Grade 4
9.860400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.451000E-01
Normal-vs-NonDiabetic
7.103800E-01
Diabetic-vs-NonDiabetic
1.770390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.478200E-01
Normal-vs-NoPancreatitis
8.667200E-01
Pancreatitis-vs-NoPancreatitis
9.801600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.972200E-01
Normal-vs-N1
8.879400E-01
N0-vs-N1
5.020600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.956400E-01
Normal-vs-TP53-NonMutant
9.057000E-01
TP53-Mutant-vs-TP53-NonMutant
8.36330000000274E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
